HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

monascorubrin

isolated from Monascus species

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - monascorubrin: 2

Experts

1.	Hish, Chih-Hsuan: 1 article (10/2007)
2.	Hsu, Wei-Yi: 1 article (10/2007)
3.	Lin, Wun-Yuan: 1 article (10/2007)
4.	Pan, Tzu-Ming: 1 article (10/2007)

Related Diseases

1.

Neoplasms (Cancer)

01/01/1994 - "It is assumed that the inhibition of tumor promotion by monascorubrin, chaetoviridin A and Monascus pigment is due to anti-inflammatory activity."
10/31/2007 - "Monascus secondary metabolites, including monacolin K, monascorubrin, and ankaflavin, have been reported to have an antiproliferative effect on cancer cells. "
01/01/1994 - "Furthermore, monascorubrin (2 mumol), chaetoviridin A (2 mumol) and Monascus pigment (1 mg) markedly suppressed the promoting effect of TPA (1 microgram) on skin tumor formation in mice initiated with 7,12-dimethylbenz[a]anthracene (50 micrograms). "

Related Drugs and Biologics

1.	Lovastatin (Mevacor)
2.	chaetoviridin A
3.	ankaflavin
4.	anthracene